Lisanti Capital Growth, LLC Crispr Therapeutics Ag Transaction History

Lisanti Capital Growth, LLC

  • $384 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$110.72 - $210.04 $615,603 - $1.17 Million
-5,560 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$79.67 - $173.23 $442,965 - $963,158
5,560 New
5,560 $851,000
Q2 2020

Aug 10, 2020
SELL
$38.5 - $76.05 $642,565 - $1.27 Million
-16,690 Closed
0 $0
Q1 2020

May 11, 2020
BUY
$33.68 - $62.53 $241,654 - $448,652
7,175 Added 75.41%
16,690 $708,000
Q4 2019

Feb 13, 2020
BUY
$36.68 - $73.13 $349,010 - $695,831
9,515 New
9,515 $580,000

Others Institutions Holding CRSP

# of Institutions
510
Shares Held
57.4M
Call Options Held
1.74M
Put Options Held
1.84M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.62B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email